Overview

Open-label Study of Safety and Tolerability of Memantine in Children With Autism

Status:
Completed
Trial end date:
2013-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the long-term safety and tolerability of memantine in the treatment of autism in pediatric patients.
Phase:
Phase 2
Details
Lead Sponsor:
Forest Laboratories
Collaborator:
Merz Pharmaceuticals GmbH
Treatments:
Memantine